Early aggressive vs. initially conservative treatment in elderly patients with non-ST-elevation acute coronary syndrome: The Italian Elderly ACS study

Journal of Cardiovascular Medicine

Volumn 9, Issue 3, 2008, Pages 217-226

  Savonitto, Stefano ^a   De Servi, Stefano ^b   Petronio, Anna Sonia ^c   Bolognese, Leonardo ^d   Cavallini, Claudio ^e   Greco, Cesare ^f   Indolfi, Ciro ^g   Visconti, Luigi Oltrona ^h   Piscione, Federico ⁱ   Ambrosio, Giuseppe ^j   Galvani, Marcello ^k   Marzocchi, Antonio ^l   Santilli, Ignazio ^a   Steffenino, Giuseppe ^m   Maseri, Attilio ⁿ  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b Civil Hospital   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d IRCCS POLICLINICO SAN DONATO   (Italy)

^e Ospedale Silvestrini   (Italy)

^f MOLINETTE HOSPITAL   (Italy)

^g UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^j UNIVERSITY OF PERUGIA   (Italy)

^k Forli Hospital   (Italy)

^l UNIVERSITY OF BOLOGNA   (Italy)

^m S CROCE E CARLE HOSPITAL   (Italy)

ⁿ SAN RAFFAELE HOSPITAL   (Italy)

more..

Author keywords

Acute coronary syndrome; Elderly; Randomized clinical trial; Registry

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CHROMIUM CHLORIDE; CLOPIDOGREL; ENOXAPARIN; EPTIFIBATIDE; HEPARIN; HIRULOG; TIROFIBAN;

ACUTE CORONARY SYNDROME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; ELECTROCARDIOGRAM; FOLLOW UP; GERIATRIC PATIENT; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL READMISSION; HUMAN; ISCHEMIA; ITALY; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; ST SEGMENT ELEVATION; STROKE;

ACUTE DISEASE; AGED; CAUSE OF DEATH; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ITALY; MYOCARDIAL REVASCULARIZATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; SYNDROME; TIME FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 40049112553     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3282f7c8df     Document Type: Article

References (44)

1. Scholte op Reimer WJM, Gitt AK, Boersma E, Simoons ML, editors. Cardiovascular diseases in Europe. Euro Heart Survey 2006. Sophia Antipolis: European Society of Cardiology; 2006.
2. Rosengren A, Wallentin L, Gitt AK, Behar S, Battler A, Hasdai D. Sex, age and clinical presentation of acute coronary syndromes. Eur Heart J 2004; 25:663-670.
3. Rosengren A, Wallentin L, Simoons M, Gitt AK, Behar S, Battler A, Hasdai D. Age, clinical presentation, and outcome of acute coronary syndromes in the Euro Heart acute coronary syndrome survey. Eur Heart J 2006; 27:789-795.
4. Di Chiara A, Chiarella F, Savonitto S, Lucci D, Bolognese L, De Servi S, et al., On behalf of the BLITZ Investigators. Epidemiology of acute myocardial infarction in the Italian CCU network. The BLITZ Study. Eur Heart J 2003; 24:1616-1629.
5. Di Chiara A, Fresco C, Savonitto S, Greco C, Lucci D, Gonzini L, et al., On behalf of the BLITZ-2 Investigators. Epidemiology of acute coronary syndromes without ST-segment elevation in the Italian CCU network. The BLITZ-2 Study. Eur Heart J 2006; 27:393-405.
6. De Servi S, Cavallini C, Dellavalle A, Santoro GM, Bonizzoni E, Marzocchi A, et al. Non-ST-elevation acute coronary syndrome in the elderly: treatment strategies and 30-day outcome. Am Heart J 2004; 147:830-836.
7. Oltrona L, Ottani F, Galvani M, Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology and the Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO). Clinical significance of a single measurement of troponin-I and C-reactive protein at admission in 1773 consecutive patients with acute coronary syndromes. Am Heart J 2004; 148:405-415.
8. Alexander KL, Newby LK, Cannon CP, Armstrong PW, Gibler WB, Rich MW, et al. Acute coronary care in the elderly. Part I: Non-ST-segment- elevation acute coronary syndromes. A scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology. In Collaboration With the Society of Geriatric Cardiology. Circulation 2007; 115:2549-2569.
9. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budai A, Fernandez-Avilès F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology. Eur Heart J 2007; 28:1598-1660.
10. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al. ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction). Circulation 2007 [Epub ahead of print].
11. Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C, et al., Guidelines for Percutaneous Coronary Interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26:804-847.
12. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Kern MJ, King SB III, Morrison DA, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for 2005 by the American College of Cardiology Foundation and the American Heart Association, Inc. Percutaneous Coronary Intervention). American Heart Association Web Site. Available at http://www.americanheart.org.
13. Anderson HV, Cannon CP, Stone PH, Williams DO, McCabe CH, Knatterud GL, et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol 1995; 26:1643-1650.
14. Bach RG, Cannon CP, Weintraub WS, DiBattiste PM, Demopoulos LA, Anderson HV, et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 2004; 141:189-195.
15. Thygesen K, Alpert JS. White HD on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the redefinition of myocardial infarction. Eur Heart J 2007; 28:2525-2538.
16. Rankin J. Cerebral vascular accidents in patients over the age of 60. Scott Med J 1957; 2:200-215.
17. Bonita R, Beaglehole R. Modification of Rankin Scale: recovery of motor function after stroke. Stroke 1988; 19:1497-1500.
18. Rao AK, Pratt C, Berke A, Jaffe A, Ockene I, Schreiber TL, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial-phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 1988; 11:1-11.
19. Rao SV, Eikelboom JA, Granger CB, Harrington RA, Califf RM, Bassand JP. Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007; 28:1193-1204.
20. Machin D, Campbell MJ. Comparing two survival curves (logrank comparisons). In: Statistical tables for the design of clinical trials. Oxford: Blackwell Scientific Publications; 1987.
21. FRagmin and Fast Revascularization during InStability in Coronary artery disease (FRISC II) Investigators. Long-term low-molecular-mass heparin in unstable coronary artery disease: FRISC II prospective randomised multicentre study [published correction appears in Lancet 1999; 354:1478]. Lancet 1999; 354:701-707.
22. Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, et al., Randomized Intervention Trial of unstable Angina Investigators. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial: Randomised Intervention Trial of unstable Angina. Lancet 2002; 360:743-751.
23. de Winter RJ, Windhausen F, Cornel JH, Dunselman PHJM, Janus CL, Bendermacher PEF, et al., For ICTUS Investigators. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 2005; 353:1095-1104.
24. Alexander KP, Roe MT, Chen AY, Lytle BL, Pollack CV Jr, Foody JM, et al., CRUSADE Investigators. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 2005; 46:1479-1487.
25. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI. A method for prognostication and therapeutic decision making. JAMA 2000; 284:835-842.
26. Avezum A, Makdisse M, Spencer F, Gore JM, Fox KA, Montalescot G, et al. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2005; 149:67-73.
27. Alexander KP, Chen AY, Roe MT, Newby LK, Gibson CM, Allen-LaPointe NM, et al. CRUSADE Investigators. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes [published correction appears in JAMA 2006; 295:628]. JAMA 2005; 294:3108-3116.
28. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high-risk patients. BMJ 2002; 324:71-86.
29. The Clopidogrel in Unstable Angina to Prevent Recurrent Ischemic Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndrome without ST-segment elevation. N Engl J Med 2001; 345:494-502.
30. The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM PLUS) Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998; 338:1488-1497.
31. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998; 339:436-443.
32. Mahaffey KW, Harrington RA, Simoons ML, Granger CB, Graffagnino C, Alberts MJ, et al., Stroke in patients with acute coronary syndromes. Incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. Circulation 1999; 99:2371-2377.
33. Mak KH, Effron MB, Moliterno DJ. Platelet glycoprotein IIb/IIIa receptor antagonist: therapeutic use in cardiovascular diseases of aging. Drugs Aging 2000; 16:179-187.
34. Memon MA, Blankenship JC, Wood GC, Frey CM, Menapace FJ. Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis from major clinical trials. Am J Med 2000; 109:213-217.
35. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization: the EPILOG Investigators. N Engl J Med 1997; 336:1689-1696.
36. The Thrombolysis in Myocardial Infarction (TIMI) 11A Investigators. Dose ranging trial of enoxaparin for unstable angina: results of TIMI 11A. J Am Coll Cardiol. 1997; 29:1474-1482.
37. Moliterno DJ, Hermiller JB, Kereiakes DJ, Yow E, Applegate RJ, Braden GA, et al. A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. J Am Coll Cardiol 2003; 42:1132-1139.
38. Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, et al. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes: a systematic overview. JAMA 2004; 292:89-96.
39. Antman EM, Cohen M, Radley D, McCabe C, Rush J, Premmereur J, Braunwald E. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. Circulation 1999; 100:1602-1608.
40. The SYNERGY Trial Investigators. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy. Primary results of the SYNERGY randomized trial. JAMA 2004; 292:45-54.
41. The OASIS-5 Investigators. Comparison of fondaprarinux and enoxaparin in acute coronary syndromes without ST-segment elevation. N Engl J Med 2006; 354;1464-1476.
42. White HD, Braunwald E, Murphy SA, Jacob AJ, Gotcheva N, Polonetsky L, Antman EM. Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25. Eur Heart J 2007; 28:1066-1071.
43. Lincoff A, Bittl J, Harrington R, Feit F, Kleiman NS, Jackman JD, et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 2003; 289:853-863.
44. Lincoff AM, Kleiman NS, Kereiakes D, Feit F, Bittl JA, Jackman JD, et al. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 Randomized Trial. JAMA 2004; 292:696-703.